Stocks · Healthcare · Medical - Care Facilities
Innovage Holding Corp. INNV
$8.96 +1.82% Close, Oct 2, 2026 · NASDAQ · Market cap $1.22B
Strong growthInexpensive vs sectorLow risk
Next earnings report: Nov 3, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin widened to 6.4% from -4.4% a year earlier.
- The stock is in an uptrend: above its 200-day average for 271 trading days, with the 50-day average above the 200-day.
- Over the past year the stock returned +72.6%, ahead of the S&P 500 by 57.6 percentage points.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 38%
- FCF growth (TTM, YoY)Top 14%
- Revenue growth, 3-year CAGRTop 43%
- Revenue growth accelerationTop 24%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 30%
- Gross marginBottom 15%
- Operating marginTop 32%
- Accruals (lower is better)Top 29%
- Net debt / EBITDA (lower is better)Top 27%
- Interest coverTop 12%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 30%
- Free-cash-flow yieldTop 21%
- EBITDA / enterprise valueTop 31%
- Sales / enterprise valueTop 14%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 16%
- 6-month returnTop 40%
- 1-year return vs S&P 500Top 21%
- Distance from 52-week highTop 45%
- Trend checklist (0–4)Top 39%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 19%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyBottom 1%
- Upside to consensus price targetBottom 47%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 42%
- Maximum drawdown, 3 yearsTop 34%
- Beta vs S&P 500 (lower is better)Top 24%
- Net debt / EBITDA (lower is better)Top 27%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 13.7% | 16.4% | ↑ |
| Gross margin | 18.0% | 21.4% | ↑ |
| Operating margin | -4.4% | 6.4% | ↑ |
| FCF margin | 2.7% | 5.1% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 16.4% | 13.7% | ↑ | Top 38% |
| Gross margin | 21.4% | 18.0% | ↑ | Bottom 15% |
| Operating margin | 6.4% | -4.4% | ↑ | Top 32% |
| Net margin | -0.3% | -4.8% | ↑ | — |
| Free-cash-flow margin | 5.1% | 2.7% | ↑ | — |
| Return on invested capital | -44.2% | — | Bottom 30% | |
| Revenue growth, 3-year CAGR | 12.9% | — | Top 43% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -12.1%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 0.1%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -1.3 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- -0.35×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 14.8×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -0.13%
- Shareholder yield
- -0.13%
- Share count change, 1 year
- +1.4%
- Share count change, 3-year CAGR
- +0.4%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Sep 9, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 3 of 8
- Average EPS surprise, last 4
- +28.4%
- Average 2-day reaction, last 8
- +1.1%
- Positive 20 days after report
- 4 of 7
Analysts
- Consensus price target
- $14.00
- Target vs current price
- +56.2%
- Analysts with a rating
- 9
- Share rating Buy or Strong Buy
- 11%
- Consensus rating
- Hold
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Sep 8, 2026 | -19.6% | -2.1% | +0.2% | — | — |
| May 5, 2026 | -466.7% | -2.6% | -9.9% | -11.6% | +42.0% |
| Feb 3, 2026 | +100.0% | -0.7% | +53.2% | +66.5% | +41.6% |
| Nov 4, 2025 | +500.0% | +2.1% | +6.5% | +6.5% | +17.1% |
| Sep 9, 2025 | +50.0% | +6.0% | +23.6% | +27.8% | +25.3% |
| May 6, 2025 | -300.0% | -1.4% | +31.5% | +40.5% | +14.9% |
| Feb 4, 2025 | -766.6% | +4.5% | -5.4% | -6.2% | -11.3% |
| Nov 5, 2024 | +0.0% | +2.9% | +1.2% | -19.2% | -40.2% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Sep 8, 2026 | $0.06 | $0.07 | -19.6% | $262.0M |
| May 5, 2026 | -$0.22 | $0.06 | -466.7% | $251.9M |
| Feb 3, 2026 | $0.08 | $0.04 | +100.0% | $239.7M |
| Nov 4, 2025 | $0.06 | $0.01 | +500.0% | $236.1M |
| Sep 9, 2025 | -$0.01 | -$0.02 | +50.0% | $221.4M |
| May 6, 2025 | -$0.08 | -$0.02 | -300.0% | $218.1M |
| Feb 4, 2025 | -$0.10 | -$0.01 | -766.6% | $209.0M |
| Nov 5, 2024 | -$0.04 | -$0.04 | +0.0% | $205.1M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (forward) | 20.3× | — | — | — |
| EV / EBITDA | 38.5× | — | — | Top 31% |
| EV / Sales | 1.22× | — | — | Top 14% |
| Free-cash-flow yield | 4.15% | — | — | Top 21% |
| Earnings yield | -0.25% | — | — | Top 30% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 271
- 50-day average slope (20 days)
- -5.4%
- 200-day average slope (20 days)
- +5.9%
- Distance from 50-day average
- -15.5%
- Distance from 200-day average
- +2.9%
- RSI (14)
- 32.3
- Relative volume
- 1.46×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 51.2%
- Volatility vs own 5-year history
- 15th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.66
- Correlation with S&P 500
- 0.15
- Current drawdown from 1-year high
- -26.0%
- Maximum drawdown, 3 years
- -59.8%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Apr 27, 2021 | Apr 8, 2025 | -89.9% | 992 days | Not yet recovered |
| Mar 11, 2021 | Mar 24, 2021 | -11.5% | 9 days | 23 days (Apr 27, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $1.22B
- EPS, diluted (TTM)
- -$0.02
- Revenue (TTM)
- $989.7M
- 52-week range
- $3.94 – $12.64
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|
| Revenue | $698.6M | $688.1M | $763.9M | $853.7M | $989.7M |
| Gross profit | $135.4M | $101.3M | $132.1M | $584.8M | $206.6M |
| Operating income | -$4.4M | -$49.4M | -$23.2M | -$29.8M | $66.3M |
| Net income | -$6.5M | -$40.7M | -$21.3M | -$30.3M | -$2.5M |
| EPS (diluted) | -$0.05 | -$0.30 | -$0.16 | -$0.22 | -$0.02 |
| Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | Q4 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $205.1M | $209.0M | $218.1M | $218.1M | $236.1M | $239.7M | $251.9M | $262.0M |
| Net income | -$4.9M | -$13.2M | -$11.4M | -$11.4M | $8.0M | $10.6M | -$29.5M | $8.3M |
| EPS (diluted) | -$0.04 | -$0.10 | -$0.08 | -$0.08 | $0.06 | $0.08 | -$0.22 | $0.06 |
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|
| Operating cash flow | $27.3M | -$36.9M | -$36.9M | $32.9M | $64.7M |
| Capital expenditure | -$38.2M | -$7.9M | -$7.9M | -$6.3M | -$14.3M |
| Free cash flow | -$10.9M | -$44.8M | -$44.8M | $26.6M | $50.4M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $0 | -$179,000 | -$179,000 | -$7.3M | $0 |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $141.3M
- Total assets
- $557.4M
- Total liabilities
- $288.6M
- Total debt
- $87.0M
- Net debt
- -$10.9M
- Shareholders’ equity
- $235.6M
As of Jun 30, 2026 (filed Sep 9, 2026).
Short interest
- Shares sold short
- 1,172,680
- Days to cover
- 3.81
- Change vs previous report
- +14.3%
FINRA short interest, settlement date Sep 15, 2026.